Delivery Order SPE2DR25D3103-SPE2DR26F9W39
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,732.24 on January 7, 2026, for the supply of Jardiance 25 mg tablets (90-count packages). The contract is a firm fixed-price delivery order with no set-aside designation, awarded by the Defense Logistics Agency (DLA), the Department of Defense's supply chain management organization responsible for medical procurement. Performance will be completed...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,464.31 on January 6, 2026, for the supply of Jardiance 25 mg tablets (90-count packages). This non-set-aside, competitively awarded contract with firm fixed pricing is funded by the Defense Logistics Agency (DLA) and is scheduled for completion by January 7, 2026. The award represents a task order issued under AmerisourceBergen's parent company,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on January 6, 2026, for the supply of Jardiance 25 mg tablets (90-count packages) with a ceiling value of $45,388.56. This firm fixed-price, competitively awarded contract involves no set-aside designation and is scheduled for completion by January 7, 2026. The contract is performed at the awardee's location in Conshohocken, Pennsylvania, and is funded by...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on December 26, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a firm fixed price ceiling value of $19,092.10. This non-set-aside, competitively awarded delivery order is scheduled for completion by December 29, 2025, and represents a routine pharmaceutical procurement supporting federal medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on October 30, 2025, by the Defense Logistics Agency (DLA) for the supply of Jardiance 10 mg tablets in quantities of 90 units. This firm fixed-price delivery order, valued at $32,598.70, is scheduled for completion by October 31, 2025, and represents a non-set-aside competitive award. The contract will be performed at the contractor's corporate office...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on November 6, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $11,878.85. This competitive, firm fixed-price delivery order is set to be completed by November 7, 2025, and represents a single-line procurement under AmerisourceBergen's larger pharmaceutical supply framework with the federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,053.12 on January 8, 2026, for 90-count tablets of Jardiance 25 mg. This is a firm fixed-price, non-set-aside contract funded by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense responsible for supplying medical and pharmaceutical products to military healthcare systems. The delivery order is expected to be...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,056.65 by the Defense Logistics Agency on November 7, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This competitively awarded, firm fixed-price contract carries an ultimate completion date of November 10, 2025, and includes no set-aside designation. The place of performance is AmerisourceBergen's corporate office in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on November 4, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price delivery order, valued at $81,211.74, is scheduled for completion by November 5, 2025, and represents a non-competitive set-aside award. The contractor will perform this work from its Conshohocken facility and fulfill the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $30,051.78 by the Defense Logistics Agency on October 20, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9W39Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $13,447.57 delivery order on January 12, 2026, for the supply of Jardiance 25 mg tablets (90-count packaging) under a firm fixed-price contract type with no set-aside designation. The award, which carries an ultimate completion date of January 13, 2026, is funded by the Defense Logistics Agency (DLA), a defense-focused federal procurement entity responsible for supply chain support to military and related healthcare systems. This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), which holds the parent-level relationship and maintains an extended Indefinite Delivery Contract with DLA valued at $999,999,999.00 through December 31, 2031. Jardiance, a diabetes management medication, represents one of several therapeutic product categories the company routinely supplies to federal medical procurement, including specialty medications, vaccines, and medical devices, demonstrating the contractor's established capability to fulfill government requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.4k | 1/11/26 |